190 related articles for article (PubMed ID: 36645160)
1. The relationship between high density lipoprotein cholesterol and sepsis: A clinical and genetic approach.
Liu G; Jiang L; Kerchberger VE; Oeser A; Ihegword A; Dickson AL; Daniel LL; Shaffer C; Linton MF; Cox N; Chung CP; Wei WQ; Stein CM; Feng Q
Clin Transl Sci; 2023 Mar; 16(3):489-501. PubMed ID: 36645160
[TBL] [Abstract][Full Text] [Related]
2. Cholesteryl Ester Transfer Protein Influences High-Density Lipoprotein Levels and Survival in Sepsis.
Trinder M; Genga KR; Kong HJ; Blauw LL; Lo C; Li X; Cirstea M; Wang Y; Rensen PCN; Russell JA; Walley KR; Boyd JH; Brunham LR
Am J Respir Crit Care Med; 2019 Apr; 199(7):854-862. PubMed ID: 30321485
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis.
Trinder M; Wang Y; Madsen CM; Ponomarev T; Bohunek L; Daisely BA; Julia Kong H; Blauw LL; Nordestgaard BG; Tybjærg-Hansen A; Wurfel MM; Russell JA; Walley KR; Rensen PCN; Boyd JH; Brunham LR
Circulation; 2021 Mar; 143(9):921-934. PubMed ID: 33228395
[TBL] [Abstract][Full Text] [Related]
4. Association of CETP Gene Variants With Risk for Vascular and Nonvascular Diseases Among Chinese Adults.
Millwood IY; Bennett DA; Holmes MV; Boxall R; Guo Y; Bian Z; Yang L; Sansome S; Chen Y; Du H; Yu C; Hacker A; Reilly DF; Tan Y; Hill MR; Chen J; Peto R; Shen H; Collins R; Clarke R; Li L; Walters RG; Chen Z;
JAMA Cardiol; 2018 Jan; 3(1):34-43. PubMed ID: 29141072
[TBL] [Abstract][Full Text] [Related]
5. CETP genetic variant rs1800777 (allele A) is associated with abnormally low HDL-C levels and increased risk of AKI during sepsis.
Genga KR; Trinder M; Kong HJ; Li X; Leung AKK; Shimada T; Walley KR; Russell JA; Francis GA; Brunham LR; Boyd JH
Sci Rep; 2018 Nov; 8(1):16764. PubMed ID: 30425299
[TBL] [Abstract][Full Text] [Related]
6. Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients.
Grion CM; Cardoso LT; Perazolo TF; Garcia AS; Barbosa DS; Morimoto HK; Matsuo T; Carrilho AJ
Eur J Clin Invest; 2010 Apr; 40(4):330-8. PubMed ID: 20486994
[TBL] [Abstract][Full Text] [Related]
7. Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
Nurmohamed NS; Ditmarsch M; Kastelein JJP
Cardiovasc Res; 2022 Nov; 118(14):2919-2931. PubMed ID: 34849601
[TBL] [Abstract][Full Text] [Related]
8. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.
Ference BA; Kastelein JJP; Ginsberg HN; Chapman MJ; Nicholls SJ; Ray KK; Packard CJ; Laufs U; Brook RD; Oliver-Williams C; Butterworth AS; Danesh J; Smith GD; Catapano AL; Sabatine MS
JAMA; 2017 Sep; 318(10):947-956. PubMed ID: 28846118
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein and high-density lipoprotein cholesterol levels in relation to genetic polymorphisms and menopausal status: the Atherosclerosis Risk in Communities (ARIC) Study.
Chamberlain AM; Folsom AR; Schreiner PJ; Boerwinkle E; Ballantyne CM
Atherosclerosis; 2008 Oct; 200(2):322-8. PubMed ID: 18275964
[TBL] [Abstract][Full Text] [Related]
10. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
Rump P; Mensink RP; Hornstra G
Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
[TBL] [Abstract][Full Text] [Related]
11. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
[TBL] [Abstract][Full Text] [Related]
13. On- and off-target pharmacology of torcetrapib: current understanding and implications for the structure activity relationships (SAR), discovery and development of cholesteryl ester-transfer protein (CETP) inhibitors.
Johns DG; Duffy J; Fisher T; Hubbard BK; Forrest MJ
Drugs; 2012 Mar; 72(4):491-507. PubMed ID: 22356288
[TBL] [Abstract][Full Text] [Related]
14. Changes in high-density lipoprotein-cholesterol subfractions with exercise training may be dependent on cholesteryl ester transfer protein (CETP) genotype.
Wilund KR; Ferrell RE; Phares DA; Goldberg AP; Hagberg JM
Metabolism; 2002 Jun; 51(6):774-8. PubMed ID: 12037734
[TBL] [Abstract][Full Text] [Related]
15. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers.
Hannuksela ML; Liinamaa MJ; Kesäniemi YA; Savolainen MJ
Atherosclerosis; 1994 Sep; 110(1):35-44. PubMed ID: 7857368
[TBL] [Abstract][Full Text] [Related]
16. A Novel Role for CETP as Immunological Gatekeeper: Raising HDL to Cure Sepsis?
Blauw LL; Wang Y; Willems van Dijk K; Rensen PCN
Trends Endocrinol Metab; 2020 May; 31(5):334-343. PubMed ID: 32033866
[TBL] [Abstract][Full Text] [Related]
17. Association Between Low-Density Lipoprotein Cholesterol Levels and Risk for Sepsis Among Patients Admitted to the Hospital With Infection.
Feng Q; Wei WQ; Chaugai S; Leon BGC; Mosley JD; Leon DAC; Jiang L; Ihegword A; Shaffer CM; Linton MF; Chung CP; Stein CM
JAMA Netw Open; 2019 Jan; 2(1):e187223. PubMed ID: 30657536
[TBL] [Abstract][Full Text] [Related]
18. TaqIB polymorphism in the CETP gene modulates the impact of HC/LF diet on the HDL profile in healthy Chinese young adults.
Du J; Fang DZ; Lin J; Xiao LY; Zhou XD; Shigdar S; Duan W
J Nutr Biochem; 2010 Nov; 21(11):1114-9. PubMed ID: 20138746
[TBL] [Abstract][Full Text] [Related]
19. A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms.
Le Goff W; Guerin M; Nicaud V; Dachet C; Luc G; Arveiler D; Ruidavets JB; Evans A; Kee F; Morrison C; Chapman MJ; Thillet J
Atherosclerosis; 2002 Apr; 161(2):269-79. PubMed ID: 11888509
[TBL] [Abstract][Full Text] [Related]
20. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study.
Ordovas JM; Cupples LA; Corella D; Otvos JD; Osgood D; Martinez A; Lahoz C; Coltell O; Wilson PW; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1323-9. PubMed ID: 10807749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
